The short version
Only one company currently supplies this market — there is no backup if it stumbles. The price has jumped 66% in a year, to $0.3144 per unit — sharp rises like this often mean supply is already tightening.
Market view
dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate · Tablet
2 marketed package NDCs · 1 active manufacturer
Most dispensed: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 852 mg; POTASSIUM PHOSPHATE, MONOBASIC 155 mg; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 130 mg · Tablet · #100 tablets/bottle
Price range and competition
RSS: changes for this drugEvery company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Sep 2026 — typical price $0.3144 · middle half $0.3144–$0.3144 · full range $0.3144–$0.3144 · 1 products · 1 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Phospha 250 NeutralAug 26, 2026Mfr enteredRising Pharma Holdings, Inc. · dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate
- Price upNADAC $0.26439 → $0.31435 per unit (+18.9%)
- Mfr exitedRising Pharma Holdings, Inc. · dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate
- Price downNADAC $0.28214 → $0.26439 per unit (-6.29%)
- Phospha 250 NeutralJul 22, 2026Mfr enteredRising Pharma Holdings, Inc. · dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate
Common questions
- Is Dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate in shortage right now?
- No. FDA does not currently list Dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate?
- 1 company has marketed Dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
- What does Dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate cost?
- The typical pharmacy pays about $0.3144 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.